APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anti-Suicide Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Anti-Suicide Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173965410322 December 2025181 pages

Choose your research edition.

Industry ResearchAnti-Suicide Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Suicide Drug Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Anti-Suicide Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Suicide Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Suicide Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Anti-Suicide Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Anti-Suicide Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-Suicide Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Suicide Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anti-Suicide Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Suicide Drug include Allergan plc, H. Lundbeck A/S, NeuroRx, Inc., AstraZeneca plc, GlaxoSmithkline plc, Pfizer, Inc., Eli Lilly and Company, Merck & Co., Inc. and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-Suicide Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-Suicide Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-Suicide Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-Suicide Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-Suicide Drug Segment by Company

Allergan plc

H. Lundbeck A/S

NeuroRx, Inc.

AstraZeneca plc

GlaxoSmithkline plc

Pfizer, Inc.

Eli Lilly and Company

Merck & Co., Inc.

Johnson & Johnson

Anti-Suicide Drug Segment by Type

Anti-Depressants and Anti-Anxiety Drugs

Antibiotic Analog

Anti-Psychotic Drugs

NMDA Antagonist

Others

Anti-Suicide Drug Segment by Application

Hospital

Clinic

Home Use

Anti-Suicide Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Suicide Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Suicide Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Suicide Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-Suicide Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Suicide Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anti-Suicide Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Anti-Suicide Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Anti-Suicide Drug Industry Trends Table 2. Anti-Suicide Drug Industry Drivers Table 3. Anti-Suicide Drug Industry Opportunities and Challenges Table 4. Anti-Suicide Drug Industry Restraints Table 5. Global Anti-Suicide Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Anti-Suicide Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Anti-Suicide Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Anti-Suicide Drug Sales Market Share by Manufacturers Table 9. Global Anti-Suicide Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Anti-Suicide Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Anti-Suicide Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Anti-Suicide Drug Manufacturers, Product Type & Application Table 13. Global Anti-Suicide Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-Suicide Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Anti-Depressants and Anti-Anxiety Drugs Table 17. Major Manufacturers of Antibiotic Analog Table 18. Major Manufacturers of Anti-Psychotic Drugs Table 19. Major Manufacturers of NMDA Antagonist Table 20. Major Manufacturers of Others Table 21. Global Anti-Suicide Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Anti-Suicide Drug Sales by Type (2021-2026) & (k units) Table 23. Global Anti-Suicide Drug Sales by Type (2027-2032) & (k units) Table 24. Global Anti-Suicide Drug Sales Market Share by Type (2021-2026) Table 25. Global Anti-Suicide Drug Sales Market Share by Type (2027-2032) Table 26. Global Anti-Suicide Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Anti-Suicide Drug Revenue by Type (2021-2026) & (k units) Table 28. Global Anti-Suicide Drug Revenue by Type (2027-2032) & (k units) Table 29. Global Anti-Suicide Drug Revenue Market Share by Type (2021-2026) Table 30. Global Anti-Suicide Drug Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Major Manufacturers of Home Use Table 34. Global Anti-Suicide Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Anti-Suicide Drug Sales by Application (2021-2026) & (k units) Table 36. Global Anti-Suicide Drug Sales by Application (2027-2032) & (k units) Table 37. Global Anti-Suicide Drug Sales Market Share by Application (2021-2026) Table 38. Global Anti-Suicide Drug Sales Market Share by Application (2027-2032) Table 39. Global Anti-Suicide Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Anti-Suicide Drug Revenue by Application (2021-2026) & (k units) Table 41. Global Anti-Suicide Drug Revenue by Application (2027-2032) & (k units) Table 42. Global Anti-Suicide Drug Revenue Market Share by Application (2021-2026) Table 43. Global Anti-Suicide Drug Revenue Market Share by Application (2027-2032) Table 44. Global Anti-Suicide Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Anti-Suicide Drug Sales by Region (2021-2026) & (k units) Table 46. Global Anti-Suicide Drug Sales Market Share by Region (2021-2026) Table 47. Global Anti-Suicide Drug Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Anti-Suicide Drug Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Anti-Suicide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Anti-Suicide Drug Sales by Country (2021-2026) & (k units) Table 51. North America Anti-Suicide Drug Sales by Country (2027-2032) & (k units) Table 52. Europe Anti-Suicide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Anti-Suicide Drug Sales by Country (2021-2026) & (k units) Table 54. Europe Anti-Suicide Drug Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Anti-Suicide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Anti-Suicide Drug Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Anti-Suicide Drug Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Anti-Suicide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Anti-Suicide Drug Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Anti-Suicide Drug Sales by Country (2027-2032) & (k units) Table 61. Global Anti-Suicide Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Anti-Suicide Drug Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Anti-Suicide Drug Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Anti-Suicide Drug Revenue Market Share by Region (2021-2026) Table 65. Global Anti-Suicide Drug Revenue Market Share by Region (2027-2032) Table 66. Allergan plc Company Information Table 67. Allergan plc Business Overview Table 68. Allergan plc Anti-Suicide Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Allergan plc Anti-Suicide Drug Product Portfolio Table 70. Allergan plc Recent Development Table 71. H. Lundbeck A/S Company Information Table 72. H. Lundbeck A/S Business Overview Table 73. H. Lundbeck A/S Anti-Suicide Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. H. Lundbeck A/S Anti-Suicide Drug Product Portfolio Table 75. H. Lundbeck A/S Recent Development Table 76. NeuroRx, Inc. Company Information Table 77. NeuroRx, Inc. Business Overview Table 78. NeuroRx, Inc. Anti-Suicide Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. NeuroRx, Inc. Anti-Suicide Drug Product Portfolio Table 80. NeuroRx, Inc. Recent Development Table 81. AstraZeneca plc Company Information Table 82. AstraZeneca plc Business Overview Table 83. AstraZeneca plc Anti-Suicide Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. AstraZeneca plc Anti-Suicide Drug Product Portfolio Table 85. AstraZeneca plc Recent Development Table 86. GlaxoSmithkline plc Company Information Table 87. GlaxoSmithkline plc Business Overview Table 88. GlaxoSmithkline plc Anti-Suicide Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. GlaxoSmithkline plc Anti-Suicide Drug Product Portfolio Table 90. GlaxoSmithkline plc Recent Development Table 91. Pfizer, Inc. Company Information Table 92. Pfizer, Inc. Business Overview Table 93. Pfizer, Inc. Anti-Suicide Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Pfizer, Inc. Anti-Suicide Drug Product Portfolio Table 95. Pfizer, Inc. Recent Development Table 96. Eli Lilly and Company Company Information Table 97. Eli Lilly and Company Business Overview Table 98. Eli Lilly and Company Anti-Suicide Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Eli Lilly and Company Anti-Suicide Drug Product Portfolio Table 100. Eli Lilly and Company Recent Development Table 101. Merck & Co., Inc. Company Information Table 102. Merck & Co., Inc. Business Overview Table 103. Merck & Co., Inc. Anti-Suicide Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Merck & Co., Inc. Anti-Suicide Drug Product Portfolio Table 105. Merck & Co., Inc. Recent Development Table 106. Johnson & Johnson Company Information Table 107. Johnson & Johnson Business Overview Table 108. Johnson & Johnson Anti-Suicide Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Johnson & Johnson Anti-Suicide Drug Product Portfolio Table 110. Johnson & Johnson Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Anti-Suicide Drug Distributors List Table 114. Anti-Suicide Drug Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Anti-Suicide Drug Product Image Figure 2. Global Anti-Suicide Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Suicide Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Suicide Drug Sales (2021-2032) & (k units) Figure 5. Global Anti-Suicide Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Anti-Suicide Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Anti-Depressants and Anti-Anxiety Drugs Image Figure 9. Antibiotic Analog Image Figure 10. Anti-Psychotic Drugs Image Figure 11. NMDA Antagonist Image Figure 12. Others Image Figure 13. Global Anti-Suicide Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Anti-Suicide Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Anti-Suicide Drug Sales Market Share by Type (2021-2032) Figure 16. Global Anti-Suicide Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Anti-Suicide Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Anti-Suicide Drug Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Home Use Image Figure 22. Global Anti-Suicide Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Anti-Suicide Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Anti-Suicide Drug Sales Market Share by Application (2021-2032) Figure 25. Global Anti-Suicide Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Anti-Suicide Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Anti-Suicide Drug Revenue Market Share by Application (2021-2032) Figure 28. North America Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Anti-Suicide Drug Sales Market Share by Country (2021-2032) Figure 30. U.S. Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Anti-Suicide Drug Sales Market Share by Country (2021-2032) Figure 35. Germany Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Anti-Suicide Drug Sales Market Share by Country (2021-2032) Figure 42. China Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Anti-Suicide Drug Sales Market Share by Country (2021-2032) Figure 50. Brazil Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Anti-Suicide Drug Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Anti-Suicide Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Anti-Suicide Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Anti-Suicide Drug Revenue (2021-2032) & (US$ Million) Figure 61. North America Anti-Suicide Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Anti-Suicide Drug Revenue (2021-2032) & (US$ Million) Figure 63. Europe Anti-Suicide Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Anti-Suicide Drug Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Anti-Suicide Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Anti-Suicide Drug Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Anti-Suicide Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Anti-Suicide Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Anti-Suicide Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-Depressants and Anti-Anxiety Drugs
  • Antibiotic Analog
  • Anti-Psychotic Drugs
  • NMDA Antagonist
  • Others
Applications
  • Hospital
  • Clinic
  • Home Use
Companies covered
  • Allergan plc
  • H. Lundbeck A/S
  • NeuroRx, Inc.
  • AstraZeneca plc
  • GlaxoSmithkline plc
  • Pfizer, Inc.
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-Suicide Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-Suicide Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Anti-Suicide Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Anti-Suicide Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Anti-Suicide Drug Market Dynamics
  1. 2.1 Anti-Suicide Drug Industry Trends
  2. 2.2 Anti-Suicide Drug Industry Drivers
  3. 2.3 Anti-Suicide Drug Industry Opportunities and Challenges
  4. 2.4 Anti-Suicide Drug Industry Restraints
3 Anti-Suicide Drug Market by Manufacturers
  1. 3.1 Global Anti-Suicide Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Anti-Suicide Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Anti-Suicide Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Anti-Suicide Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Suicide Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Anti-Suicide Drug Manufacturers, Product Type & Application
  7. 3.7 Global Anti-Suicide Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Suicide Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Suicide Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Suicide Drug Tier 1, Tier 2, and Tier 3
4 Anti-Suicide Drug Market by Type
  1. 4.1 Anti-Suicide Drug Type Introduction
  2. 4.1.1 Anti-Depressants and Anti-Anxiety Drugs
  3. 4.1.2 Antibiotic Analog
  4. 4.1.3 Anti-Psychotic Drugs
  5. 4.1.4 NMDA Antagonist
  6. 4.1.5 Others
  7. 4.2 Global Anti-Suicide Drug Sales by Type
  8. 4.2.1 Global Anti-Suicide Drug Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Anti-Suicide Drug Sales by Type (2021-2032)
  10. 4.2.3 Global Anti-Suicide Drug Sales Market Share by Type (2021-2032)
  11. 4.3 Global Anti-Suicide Drug Revenue by Type
  12. 4.3.1 Global Anti-Suicide Drug Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Anti-Suicide Drug Revenue by Type (2021-2032)
  14. 4.3.3 Global Anti-Suicide Drug Revenue Market Share by Type (2021-2032)
5 Anti-Suicide Drug Market by Application
  1. 5.1 Anti-Suicide Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Home Use
  5. 5.2 Global Anti-Suicide Drug Sales by Application
  6. 5.2.1 Global Anti-Suicide Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-Suicide Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Anti-Suicide Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Anti-Suicide Drug Revenue by Application
  10. 5.3.1 Global Anti-Suicide Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Anti-Suicide Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Anti-Suicide Drug Revenue Market Share by Application (2021-2032)
6 Global Anti-Suicide Drug Sales by Region
  1. 6.1 Global Anti-Suicide Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-Suicide Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-Suicide Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Anti-Suicide Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-Suicide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Anti-Suicide Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Anti-Suicide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Anti-Suicide Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Anti-Suicide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Anti-Suicide Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Anti-Suicide Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Anti-Suicide Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Anti-Suicide Drug Revenue by Region
  1. 7.1 Global Anti-Suicide Drug Revenue by Region
  2. 7.1.1 Global Anti-Suicide Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Anti-Suicide Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Anti-Suicide Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Anti-Suicide Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Anti-Suicide Drug Revenue (2021-2032)
  8. 7.2.2 North America Anti-Suicide Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Anti-Suicide Drug Revenue (2021-2032)
  11. 7.3.2 Europe Anti-Suicide Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Anti-Suicide Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Anti-Suicide Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Anti-Suicide Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Anti-Suicide Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Allergan plc
  2. 8.1.1 Allergan plc Company Information
  3. 8.1.2 Allergan plc Business Overview
  4. 8.1.3 Allergan plc Anti-Suicide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Allergan plc Anti-Suicide Drug Product Portfolio
  6. 8.1.5 Allergan plc Recent Developments
  7. 8.2 H. Lundbeck A/S
  8. 8.2.1 H. Lundbeck A/S Company Information
  9. 8.2.2 H. Lundbeck A/S Business Overview
  10. 8.2.3 H. Lundbeck A/S Anti-Suicide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 H. Lundbeck A/S Anti-Suicide Drug Product Portfolio
  12. 8.2.5 H. Lundbeck A/S Recent Developments
  13. 8.3 NeuroRx, Inc.
  14. 8.3.1 NeuroRx, Inc. Company Information
  15. 8.3.2 NeuroRx, Inc. Business Overview
  16. 8.3.3 NeuroRx, Inc. Anti-Suicide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 NeuroRx, Inc. Anti-Suicide Drug Product Portfolio
  18. 8.3.5 NeuroRx, Inc. Recent Developments
  19. 8.4 AstraZeneca plc
  20. 8.4.1 AstraZeneca plc Company Information
  21. 8.4.2 AstraZeneca plc Business Overview
  22. 8.4.3 AstraZeneca plc Anti-Suicide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca plc Anti-Suicide Drug Product Portfolio
  24. 8.4.5 AstraZeneca plc Recent Developments
  25. 8.5 GlaxoSmithkline plc
  26. 8.5.1 GlaxoSmithkline plc Company Information
  27. 8.5.2 GlaxoSmithkline plc Business Overview
  28. 8.5.3 GlaxoSmithkline plc Anti-Suicide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithkline plc Anti-Suicide Drug Product Portfolio
  30. 8.5.5 GlaxoSmithkline plc Recent Developments
  31. 8.6 Pfizer, Inc.
  32. 8.6.1 Pfizer, Inc. Company Information
  33. 8.6.2 Pfizer, Inc. Business Overview
  34. 8.6.3 Pfizer, Inc. Anti-Suicide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer, Inc. Anti-Suicide Drug Product Portfolio
  36. 8.6.5 Pfizer, Inc. Recent Developments
  37. 8.7 Eli Lilly and Company
  38. 8.7.1 Eli Lilly and Company Company Information
  39. 8.7.2 Eli Lilly and Company Business Overview
  40. 8.7.3 Eli Lilly and Company Anti-Suicide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eli Lilly and Company Anti-Suicide Drug Product Portfolio
  42. 8.7.5 Eli Lilly and Company Recent Developments
  43. 8.8 Merck & Co., Inc.
  44. 8.8.1 Merck & Co., Inc. Company Information
  45. 8.8.2 Merck & Co., Inc. Business Overview
  46. 8.8.3 Merck & Co., Inc. Anti-Suicide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck & Co., Inc. Anti-Suicide Drug Product Portfolio
  48. 8.8.5 Merck & Co., Inc. Recent Developments
  49. 8.9 Johnson & Johnson
  50. 8.9.1 Johnson & Johnson Company Information
  51. 8.9.2 Johnson & Johnson Business Overview
  52. 8.9.3 Johnson & Johnson Anti-Suicide Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Johnson & Johnson Anti-Suicide Drug Product Portfolio
  54. 8.9.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-Suicide Drug Value Chain Analysis
  2. 9.1.1 Anti-Suicide Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-Suicide Drug Production Mode & Process
  6. 9.2 Anti-Suicide Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-Suicide Drug Distributors
  9. 9.2.3 Anti-Suicide Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst